|
Mammo Screening Saves Lives, Rad Shortage, and More on LLM Reports
February 19, 2026
|
|
|
|
|
Together with
|
|
|
|
“I really hope I’m wrong about this but Meaningful Use for Healthcare AI is coming. I can just sense it. I’m not even a clinician and I’ve still got lingering EHR-mandate PTSD.”
|
|
Jeremy Bikman of healthcare growth accelerator Reaction.
|
|
|
|
A new study confirms that not only does breast cancer screening save lives, but it also improves survival in women with late-stage disease. Researchers found that women with stage IV breast cancer had a survival rate over three times higher if their disease was detected with screening, thanks largely to its role in driving treatment.
The “Mammography Wars” over breast cancer screening’s effectiveness raged from the 1980s to the 2010s, but eventually were decided in mammography’s favor.
- Multiple research studies have demonstrated that the combination of early detection and more effective treatments improve breast cancer survival. The USPSTF’s 2023 shift back to recommending that screening start at 40 settled the issue.
But pockets of anti-screening resistance remain, with screening skeptics publishing several studies since the USPSTF change questioning the value not only of mammography but also other cancer screening tests.
- So it’s more important than ever to demonstrate cancer screening’s value.
The new study in the Journal of the National Cancer Institute does just that by analyzing screening’s impact on survival rates in women diagnosed with stage IV disease who had been invited to Denmark’s national breast screening program (not all women completed mammography despite getting invited).
- In all, 32.8k women with breast cancer were included, of whom 8% presented with stage III or stage IV cancer.
The researchers found that for women with stage IV breast cancer…
- Five-year survival was over 2X higher for women with screen-detected cancer versus women who were never screened (75% vs. 32%).
- Ten-year survival was over 3X higher (62% vs. 17%).
- Women with later-stage disease detected by screening had survival rates over five years comparable to women with disease one stage lower who were never screened.
- Survival rates were strongly influenced by treatment type, with surgical treatment showing the longest median survival versus non-surgical treatment and no treatment (6, 2, and 0.1 years, respectively).
The big difference in survival was driven by the fact that women with screen-detected cancers were far more likely to get surgical treatment, and to subsequently have better 10-year survival rates than those treated without surgery (60% vs. 8%).
The Takeaway
The new study once again proves the value of screening mammography, but it goes beyond just showing that screening causes a stage shift to earlier diagnosis. Even in women with late-stage disease, screening is driving more effective treatment that is proving invaluable in saving women’s lives.
|
|
A Passion for Change
United Imaging’s passion for change was on display at RSNA 2025 with the launch of new products across multiple modalities, including the new uSonique ultrasound family shown as works-in-progress. Find out what drives the company on this page.
|
|
Echo AI for Cardiac Amyloidosis
AI is reshaping the way cardiac amyloidosis is detected. A notable example is Us2.ai’s pattern recognition model, which can identify the disease from a single apical four‑chamber echo view.
|
|
- Shortage of Breast Imaging Radiologists: Despite the proven value of breast cancer screening, the field is experiencing a severe shortage of breast imaging radiologists. A new report from healthcare recruiter Medicus breaks down the situation, finding there are 7.5k breast radiologists in the U.S., or four per 100k women over age 40. The USPSTF’s lowering of the breast screening starting age expanded the mammography market by 20M newly eligible women, and 79% of practices report already being short-staffed.
- More on LLM Report Generation: Large language models are being looked at as tools for simplifying radiology reports for patients, and a new meta-analysis in The Lancet Digital Health provides strong support. Across 38 studies analyzed, 13k simplified reports were studied, with patients rating LLM reports as 87% more understandable on a five-point scale versus original reports (4.04 vs. 2.16). On the downside, 7.2% of LLM reports had errors, and 0.9% were clinically significant. Clinician oversight is still essential.
- AI of Cardiac MRI Predicts MACE: Researchers from China developed a machine learning model to predict which patients with ST-segment elevation myocardial infarction would go on to have other major adverse cardiovascular events. In a study in Radiology with 1.1k STEMI patients, their algorithm performed better than clinical models in predicting MACE at a median of 40 months (AUC = 0.91 vs. 0.62-0.86). AI models could make it easier to use cardiac MRI, such as by embedding algorithms in post-processing for use as decision support.
- GE Gets BARDA Boost for AI-Powered Ultrasound: GE HealthCare’s project to develop AI-powered ultrasound tools will be getting a $35M expansion, with most of the funding provided by the U.S. Biomedical Advanced Research and Development Authority. GE and BARDA first announced the program in 2023 to develop next-generation POCUS scanners with new AI-based applications. The expansion will fund tools for more detailed assessment of lung pathologies and improving detection of intra-abdominal injuries.
- Is Submillisievert CT a Clinical Reality? As radiology focuses on techniques to conduct lower-dose CT scans, researchers from China shared their experience with a < 1 mSv thoracic CT protocol using GE HealthCare’s deep learning image reconstruction protocols. In a paper in European Radiology, researchers compared standard-dose CT to a low-dose submillisievert protocol with two strengths of DLIR. In 214 patients, radiation dose was cut significantly (from 3.68 to under 1 mSv), while image quality was rated highest with high-strength DLIR.
- Quadruple-Low PCCT Cuts Radiation Dose: Another technology that can reduce CT radiation dose is photon-counting CT. Researchers from China showed how in a new paper in Radiology in which PCCT with a “quadruple low” protocol (low radiation and low contrast rate, volume, and concentration) was compared to conventional energy-integrating CT in 425 lung cancer patients. Quadruple-low PCCT reduced mean effective radiation dose by 55% (3.49 vs. 7.82 mSv) while also reducing contrast injection rate, volume, and concentration (33%, 22%, and 9%, respectively).
- Risk-Based CT Lung Screening: Risk-based cancer screening is hot, and Italian researchers applied the concept to CT lung cancer screening in a new paper in Journal of Thoracic Oncology. They combined molecular and immune blood tests to characterize lung nodule aggressiveness in 304 people who smoked heavily. Over 7.5 years of follow-up, the combined molecular/immune scores had 96% sensitivity for predicting lung cancer within two years and could enable 30% of patients to shift from annual to biennial screening.
- Median Taps Muduroglu as CEO of U.S. Unit: AI software developer Median Technologies is turning to a medical imaging industry veteran to spearhead its launch of the recently cleared eyonis LCS software in the U.S. The company tapped Oran Muduroglu as president of Median eyonis, its new U.S. subsidiary. Muduroglu has a long pedigree in radiology with a history of successful startup exits, including Cemax (sold to 3M/Imation), Stentor (Philips), and Medicalis (Siemens Healthineers).
- Imaging for Maxillofacial Trauma: Many patients with maxillofacial trauma are still getting X-ray despite guidelines indicating they should be sent straight to CT. A study in JAMA Network Open found that among 281k patients studied from 2013 to 2022, plain radiography use declined but was still significant (33% to 18%). In all, 5.5% got a follow-up CT scan within seven days and 7.6% experienced a diagnostic delay, leading researchers to characterize X-ray as a low-value test that should be omitted in cases of facial trauma.
- Real-World Opportunistic Screening: A Michigan health system launched a real-world opportunistic screening program to detect cardiovascular disease using AI solutions from Bunkerhill Health. McLaren Heart & Vascular Institute is using Bunkerhill’s iCAC and iAVC algorithms to analyze CT scans acquired for other clinical indications to detect incidental calcium in the coronary arteries and aortic valves. McLaren has begun scanning routine chest CT studies acquired in the past 12 months, and reports good results.
- Ultralow-Field MRI for Breast Screening: Early tests of an ultralow-field MRI scanner at Mass General Brigham show it could be useful for breast imaging. MGB researchers in a study published in Scientific Reports scanned 14 participants, and three radiologists found they could identify essential breast features and distinguish fibroglandular tissue from adipose tissue. ULF-MRI could have advantages over standard MRI scanners for breast imaging thanks to its lower cost, which could bring the technology to more clinical settings.
- Mammotome’s In-Room MRI Breast Biopsy: Mammotome this week launched Mammotome Prima MR, a dual vacuum-assisted breast biopsy device that can be positioned inside the MRI suite. Siting the device within the scanning suite improves clinician coordination, and it also includes other enhancements like a stronger vacuum and an 8-gauge needle that enable larger tissue samples to be acquired. Mammotome will display the device at ECR 2026, and it has secured the CE Mark.
- Coreline’s Zero-Click Partnership with Infinitt: Coreline Soft and Infinitt have integrated their software to make Coreline’s AVIEW AI algorithms available to Infinitt PACS users in the U.S. without requiring additional mouse clicks, logins, or manual uploads. The integration creates a zero-click workflow that moves AI from being an add-on tool to becoming an integral component of radiology operations. The first site using the integrated software is ImageCare Radiology in New Jersey.
- Big U.K. Telerad Acquisition: In a major consolidation of U.K. remote teleradiology service providers, Medica Group acquired Axon Diagnostics, creating a powerhouse remote reading company that supports over 2.5M patients a year and serves more than 50% of NHS trusts. The acquisition includes Axon’s MITIS Health sister company, whose Clinical Desktop technology for high-fidelity reporting is in use at many NHS trusts.
|
|
Meet Merge at HIMSS 2026
Built with clinical and technical expertise, guided by customer insights, and personalized to your needs, Merge imaging solutions deliver reliable imaging, less complexity, and better care. Schedule a HIMSS 2026 meeting to see how Merge can help you meet your goals.
|
|
Streamlining Sonographer Workflows
Alaska Radiology Associates needed to streamline sonographer workflows, so they turned to SonoReview by Kailo Medical. Learn how the solution enhanced accuracy and saved valuable time for both radiologists and sonographers.
|
|
A Best in KLAS Hat Trick
AGFA HealthCare was named Best in KLAS in three enterprise imaging segments this year: PACS under 300k studies, universal viewer, and vendor-neutral archive. Find out what makes customers keep coming back on this page.
|
|
- Radiology Automation Simplified: CARPL is an enterprise-grade radiology AI validation and deployment platform with 250+ AI applications across 85+ AI vendors that empowers healthcare providers to access, assess, and securely integrate imaging AI in their practice. Book a demo today.
- Interpretation Efficiency in Radiology – A Critical Strategy: Healthcare institutions are at a critical stage, where an emphasis on interpretation efficiency needs to be a priority. Check out this white paper from Visage Imaging and Signify Research on strategies to optimize your interpretation efficiency.
- A New Era of Imaging Technology: MosaicOS is the cloud-native and AI-native operating system from Mosaic Clinical Technologies designed to expand capacity, cut reporting time, and deliver faster, smarter patient care. Discover how it can improve your radiology operations today.
- It’s Time to Make AI Adoption Simple: Gleamer unifies a fragmented AI landscape into a single, simple, powerful platform with GleamerOS. Discover an AI ecosystem where everything is designed to be intuitive, consistent, and scalable, making AI adoption simpler than ever.
- Shifting the Stage in Lung Cancer Screening: Watch this video from Riverain Technologies to learn how their ClearRead CT solution for lung cancer screening can drive enrollment, earlier detection, and seamless management of incidental findings.
- Cut Repetitive Manual Tasks: Discover how Rad AI’s radiology reporting software helps you speak less and say more by reducing dictation times up to 50% and words dictated up to 90%. Join 9 of the top 10 radiology practices using Rad AI to improve efficiency.
- A Global Customer Reach: Mach7 Technologies serves a diverse range of healthcare organizations worldwide, from large integrated delivery networks to smaller community hospitals and imaging centers. Learn what Mach7 can do for you.
- Will Radiologists Lead or Be Led? Radiology is facing a defining moment. In this episode of The Radiology Report, host Daniel Arnold of Medality sat down with Frank Lexa, MD, to talk candidly about what comes next for the specialty.
- Every Image Tells a Story: Intelerad’s enterprise image management solutions are empowering radiologists and patients while transforming radiology workflows. Learn about the technologies they highlighted at RSNA 2025 for empowering imaging professionals.
- The Power of a Smooth Go-Live: Don’t gamble on your healthcare institution’s go-live: take control of your PACS migration with ENDEX from Enlitic. Discover how ENDEX uses AI to standardize, normalize, and cleanse your imaging metadata before migration.
- Transform Imaging Data into Actionable Predictions: When you choose Quibim, you get more than a partner for detecting and diagnosing prostate cancer on MRI scans. Learn how they can help you transform imaging data into actionable predictions by booking a demo today.
- The Next Generation of Universal Remote Imaging: Step into the next generation of universal remote imaging with LUMINOS Q.namix R from Siemens Healthineers. Designed for intuitive operation and patient comfort, this award-winning system sets a new standard in fluoroscopy. Explore its precision and efficiency.
- Elevating Breast Cancer Detection: Breast Suite from DeepHealth is a new package of AI-powered solutions delivering increased breast cancer detection rates, risk stratification tools, and viewing and reporting workflow acceleration. Find out how it can benefit your practice today.
- A New Solution for Radiology Reporting: Sectra Reporting delivers a fully built-in, AI-enhanced reporting experience that seamlessly connects PACS imaging data and measurements through intuitive templates. Discover how it can meet your needs today.
- Meeting Demand for Cardiovascular CT: Nagano-Chuo Hospital in Japan was visionary by introducing cardiac CT in 2006. Today, the hospital is meeting growing demand for cardiovascular imaging by upgrading their Philips Incisive CT scanner. Read their story today.
|
|
|
|
|
